CRESCENT BIOPHARMA, INC. (CBIO) Shareholders’ equity 2016–2025
CRESCENT BIOPHARMA, INC. (CBIO) shareholders’ equity at each fiscal year-end, per SEC filings.
$203.0MFY2025 · since FY2016: $35.3M → $203.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $203.0M | — |
| FY2023 | $38.4M | -10.5% |
| FY2022 | $42.9M | -47.4% |
| FY2021 | $81.6M | -36.4% |
| FY2020 | $128.2M | — |
| FY2016 | $35.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice